Anil Singhvi bullish on 2 pharma, 1 bluechip and 1 midcap stock to buy; check targets and stop losses

The markets are expected to see high volatility amid trade deal buzz between India and the US. As we write, Nifty has been trending lower with the index having dropped below 25,500 levels. So, as the momentum looks good in some of the pharma names after President's relaxation on the pharma bucket, Zee Business Managing Editor recommends a slew of stocks.